We are international
Donate
TEXT SIZE   

Call the IMF Hotline. We are here for you. The IMF Office is open from 8:00AM - 5:00PM PST, Monday-Friday.

If you have a question, call the IMF InfoLine at (800) 452-CURE (800-452-2873) in the US and Canada. The InfoLine is open from 9:00 - 4:00 PT Monday - Friday. Elsewhere call (818) 487-7455. You can also contact us via the web.
IMF - Home Page
previous     next      view all

Highlights from the 5th Annual IMWG Summit: New Myeloma Testing Method and Diagnostic Criteria
The IMF's International Myeloma Working Group (IMWG) held its 5th Annual Summit this year in Milan, Italy on June 9th-11th. This research division of the IMF now has more than 170 members worldwide. The mission of the IMWG Summit is to identify, support, and implement the most promising research to prevent onset of active disease, improve treatment, and find a cure for myeloma. This year's Summit featured a packed agenda. A full report from the Summit by IMF Medical Writer Debbie Birns will be available in two parts. Part 1 today summarizes the first two keynote lectures. The major outcomes from this year's Summit are also presented in IMF Chairman Dr. Brian Durie's teleconference "2014 Mid-Year Update: Post ASCO/EHA/IMWG."

Dr. Brian Durie's Myeloma Updates 2014: Post ASCO/EHA/IMWG teleconference
Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in June 2014. Dr. Brian G.M. Durie will explain what's new and exciting from the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG) Thursday, June 26, 2014 at 4:00 PM

The International Myeloma Foundation (IMF) Applauds Ohio Gov. Kasich for Signing SB 99 (The Cancer Treatment Modernization Act) into Law

The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – applauds Gov. John Kasich of Ohio for signing SB 99, The Cancer Treatment Modernization Act, into law. The bill requires that health plans regulated by the state that provide coverage for IV and oral anticancer treatments not exceed $100 copayment or coinsurance for a 30-day supply of orally administered anticancer treatment.


International Myeloma Foundation Announces Affiliation with Korea Blood Cancer Association

- Organizations Will Work Together to Support Myeloma Patients & Physicians in Korea

- IMF Adds to Its Growing Affiliations with Organizations around the World


Watch the webcast of the IMWG Conference Series "Making Sense of Treatment" held in Milan, Italy
IMWG Myeloma Experts debate the latest trends in treatment June 11, 2014 Milan, Italy

International Myeloma Foundation’s 5th Annual IMWG Summit to Share Latest Myeloma Developments with Patients & Clinicians Around the World

- Summit Brings Together Global Myeloma Researchers, Clinicians, and Advocates

- IMWG Conference Series Live Stream Scheduled for June 11th


IMF's Michael S. Katz Honored with ASCO's Partners in Progress Award

Mr. Katz was chosen as this year’s recipient because of his efforts to raise awareness and education about myeloma in addition to his participation in the development of clinical trials of new drugs to treat this disease. He currently serves as vice president and as an executive board member of the International Myeloma Foundation (IMF) and is a member of the Eastern Cooperative Oncology Group’s (ECOG) Executive Committee.


The IMF Reaches Out to Myeloma Patients in Italy

The IMF continued its outreach to myeloma patients around the world by co-sponsoring a patient meeting in Bari, Italy, along with the Italian blood cancer patient group AIL Pazienti (Associazione Italiana contro le Leucemie, Linfomi e Mieloma).


The International Myeloma Foundation Says Virotherapy Approach to Myeloma Could Lead to New Treatment Options

-- Mayo Clinic Team Reports a Remission in Myeloma Patient Treated with a Massive Dose of Engineered Measles Virus

-- A New Path Forward in Myeloma Research Stirs Excitement in the Myeloma Community 


Encouraging New Research About Virotherapy for Myeloma
The IMF is very pleased to see research from Dr. Stephen Russell at the Mayo Clinic achieving success and starting to make a difference for patients.

previous     next      view all